BCR-ABL1-Negative Chronic Myeloproliferative Neoplasms and Pulmonary Hypertension: A Prospective Long-Term Follow-up Study of the Impact of Pulmonary Hypertension on Survival

Payzin, Kadriye; Savasoglu, Kaan; ALACACIOĞLU, İNCİ; Dalgic, Elif; Kucukzeybek, Betul; Calli, Aylin; Bener, Sadi; PAYZIN, SERDAR

doi:10.1016/j.clml.2020.08.006

BCR-ABL1-Negative Chronic Myeloproliferative Neoplasms and Pulmonary Hypertension: A Prospective Long-Term Follow-up Study of the Impact of Pulmonary Hypertension on Survival

Payzin K. B., Savasoglu K., ALACACIOĞLU İ., Dalgic E. E., Kucukzeybek B. B., Calli A. O., ...Daha Fazla

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.21, sa.2, ss.125-131, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 2
Basım Tarihi: 2021
Doi Numarası: 10.1016/j.clml.2020.08.006
Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
Sayfa Sayıları: ss.125-131
Anahtar Kelimeler: Essential thrombocythemia, JAK2 mutation, Polycythemia vera, Primary myelofibrosis, Pulmonary hypertension
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

This prospective study assessed the prevalence of pulmonary hypertension (PHT) related to chronic myeloproliferative neoplasms (CMPNs) and evaluated the impact of PHT on survival during long-term follow-up. In a large group of BCR-ABL1-negative CMPN patients, there was a low prevalence of PHT. The impact of PHT on survival was negligible.